Taken together, our in vivo data indicate that the new NAMPT inhibitors delayed and/or prevented tumor growth in a mouse Burkitt lymphoma model, with JJ08 being the most potent anticancer agent. This evidence concerns the gene NAMPT and Burkitt lymphoma.